Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2012-03-15 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Acquisition of own shares_NL (15-03).pdf
Transaction in Own Shares Classification · 99% confidence The document is a press release written in Dutch, dated March 15, 2012, and is explicitly labeled as 'gereguleerde informatie' (regulated information). The core content details the purchase of UCB shares on the stock exchange ('Aankoop van eigen aandelen') and explicitly states these shares were delivered to personnel who exercised stock options. This activity—the company buying back its own shares, often related to employee compensation or incentive plans—directly corresponds to the definition of 'Transaction in Own Shares' (POS). The title translates to 'Purchase of own shares in the context of long-term incentives granted to staff'. This is a clear indicator of a share repurchase program execution, fitting the POS code. It is not a general Earnings Release (ER), nor is it a comprehensive Annual Report (10-K) or Interim Report (IR). Since it is a specific transaction announcement, POS is the most accurate classification.
2012-03-15 Dutch
Acquisition of own shares_ENG (08-03).pdf
Transaction in Own Shares Classification · 99% confidence The document title explicitly states "Acquisition of own shares in the framework of employees' long-term incentive plans" and details the number of shares acquired on specific dates. This directly relates to the company buying back or dealing in its own shares for internal purposes (employee plans). This aligns perfectly with the definition for Transaction in Own Shares (POS), which covers share repurchase/issuance activities.
2012-03-08 English
Acquisition of own shares_FR (08-03).pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Acquisition d'actions propres dans le cadre de rémunérations variables à long terme du personnel" (Acquisition of own shares within the framework of long-term variable remuneration for personnel). The text explicitly details the acquisition of UCB shares by the company itself, listing dates, prices, and the number of shares bought back. This action directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares'. The corresponding code is POS.
2012-03-08 French
Acquisition of own shares_NL (08-03).pdf
Transaction in Own Shares Classification · 99% confidence The document is a press release, indicated by the structure, the date/time stamp, and the presence of 'gereguleerde informatie' (regulated information). The core content details the purchase of 15,200 UCB shares on specific dates and prices, explicitly stating these shares were delivered to personnel who exercised stock options. This action—the company buying back its own shares (Aankoop van eigen aandelen) for employee incentive plans—directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The document length is short (4480 chars), but it is a substantive announcement of a transaction, not merely an announcement of a report, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule for this specific content type. The code POS (Transaction in Own Shares) is the most accurate fit.
2012-03-08 Dutch
2011 annual report - FR - dynamic.pdf
Annual Report Classification · 95% confidence The document is a 'Lettre aux parties prenantes' (Letter to Stakeholders) from UCB, which serves as the introductory narrative section of an Annual Report. It contains detailed financial performance summaries for 2011, strategic outlooks, pipeline updates, and management commentary on business operations. While it is a portion of the annual report, it functions as the core management discussion and analysis of the company's yearly performance. FY 2011
2012-03-02 French
2011 annual report - NL - dynamic.pdf
Annual Report Classification · 95% confidence The document is a comprehensive review of UCB's performance, strategy, and financial outlook for the fiscal year 2011. It includes a 'Letter to Stakeholders' from the Chairman and CEO, detailed discussions on product portfolios (Cimzia, Vimpat, Neupro, Keppra), R&D pipeline updates, financial targets, and dividend proposals. Given the depth of the content, the inclusion of financial metrics, and the strategic overview, it functions as an Annual Report. Although it is an excerpt, it contains the substantive narrative and financial data characteristic of an Annual Report (10-K equivalent for non-US entities). FY 2011
2012-03-02 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.